Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR 0.0096
+0.0002 (2.13%)
Jul 24, 2026, 12:40 PM CET
Fidia Revenue
In the year 2025, Fidia had annual revenue of 29.49M EUR with 39.76% growth. Fidia had revenue of 555.00K in the half year ending December 31, 2025, a decrease of -96.93%.
Revenue (ttm)
28.68M
Revenue Growth
-6.74%
P/S Ratio
0.15
Revenue / Employee
209.33K
Employees
146
Market Cap
4.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.49M | 8.39M | 39.76% |
| Dec 31, 2024 | 21.10M | -9.05M | -30.02% |
| Dec 31, 2023 | 30.15M | 5.54M | 22.52% |
| Dec 31, 2022 | 24.61M | 573.00K | 2.38% |
| Dec 31, 2021 | 24.03M | 2.27M | 10.43% |
| Dec 31, 2020 | 21.76M | -26.24M | -54.66% |
| Dec 31, 2019 | 48.00M | -10.91M | -18.52% |
| Dec 31, 2018 | 58.92M | 10.96M | 22.84% |
| Dec 31, 2017 | 47.96M | -11.66M | -19.56% |
| Dec 31, 2016 | 59.62M | -3.71M | -5.86% |
| Dec 31, 2015 | 63.33M | 6.02M | 10.51% |
| Dec 31, 2014 | 57.31M | 11.53M | 25.18% |
| Dec 31, 2013 | 45.78M | -3.94M | -7.93% |
| Dec 31, 2012 | 49.72M | 4.20M | 9.21% |
| Dec 31, 2011 | 45.53M | -3.24M | -6.64% |
| Dec 31, 2007 | 48.76M | 6.64M | 15.76% |
| Dec 31, 2006 | 42.13M | 7.21M | 20.64% |
| Dec 31, 2005 | 34.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EuroGroup Laminations | 823.05M |
| Biesse | 655.28M |
| SIT S.p.A. | 321.40M |
| Tesmec | 262.17M |
| ILPRA | 86.81M |
| Marzocchi Pompe | 37.47M |
| OSAI Automation System | 34.56M |
| Valtecne | 31.33M |
Fidia News
- 11 hours ago - An FDA Panel Just Endorsed These Unproven Peptides - WIRED
- 11 hours ago - FDA panel recommends easing restrictions on several peptides - NBC News
- 12 hours ago - Eli Lilly Cleared Two More Trials For Its Next-Generation Obesity Drug. It Will Seek FDA Approval Next Year - IBTimes
- 12 hours ago - FDA panel recommends controversial treatments - NBC News
- 14 hours ago - An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition - TIME
- 16 hours ago - Shortage of butter hits city bakeries, may take 10 days for issue to resolve - The Times of India
- 16 hours ago - HIMS Shares Surge Over 10% Following FDA Panel Decision - GuruFocus
- 16 hours ago - FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list - Yahoo